Abstract
The poor prognosis of children with osteosarcoma treated with amputation alone or with irradiation followed by amputation has been amply confirmed in the literature. In a retrospective survey in our institution carried out over the years 1965–1975, the 3-year survival rate was 5%.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Rosen G, Marcove RC, Caparros B, et al. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163–2177, 1979.
Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of post-operative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230, 1982.
Provisor A, Nachman J, Krailo M, et al. Treatment of non-metastatic osteogenic sarcoma (OS) of the extremities with pre and post-operative chemotherapy. Proc Am Soc Clin Oncol 6:217, abstr 855, 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ekert, H., Tiedemann, K. (1993). Osteosarcoma: Experience with the Rosen T10 protocol at RCH, Melbourne. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_44
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3518-8_44
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6561-7
Online ISBN: 978-1-4615-3518-8
eBook Packages: Springer Book Archive